Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00205192 · ClinicalTrials.gov registry record

Optimizing Cardiac Resynchronization

A clinical trial, sponsored by University of Wisconsin, Madison.

Completed
Registry status
100
Enrollment target

NCT00205192: Completed study, sponsored by University of Wisconsin, Madison.

NCT00205192 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00205192 has completed, sponsored by University of Wisconsin, Madison.

COMPLETED
Registry status
100 participants
Enrollment target

Study Summary

Cardiac resynchronization therapy shows great promise as a method to improve ventricular function in heart failure due to dilated cardiomyopathy. It is applied to patients with class III and IV symptomatic heart failure on optimal therapy. Typical entry criteria in the trials testing resynchronization have used the electrocardiogram and a prolonged electrocardiogram (ECG) QRS interval as criteria for dyssynchrony. This is recognized to be quite limited as a tool for identifying patients. Several new echocardiographic methods for identifying dyssynchrony have been proposed. The purpose of this study is to systematically examine these multiple echocardiographic measurement techniques in three conditions: 1. in the patient's native rhythm simulated by changing the pacing system to atrial pacing only; 2. in conventional dual chamber pacing (DDD mode); and 3. during biventricular pacing. All patients entered into this study will already have had a biventricular pacemaker placed.

Interventions

  • PROCEDURE Cardiac resynchronization pacing

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2004-06
Est. Completion 2011-12
University of Wisconsin, Madison

1,039 total trials

What the finished NCT00205192 record still lists

NCT00205192 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which Cardiac resynchronization pacing is the first listed.

NCT00205192 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00205192 about?

NCT00205192 is a clinical study titled "Optimizing Cardiac Resynchronization". Cardiac resynchronization therapy shows great promise as a method to improve ventricular function in heart failure due to dilated cardiomyopathy. It is applied to patients with class III and IV symptomatic heart failure on optimal therapy. Typical entry criteria in the trials testing resynchronizati...

What is the current status of trial NCT00205192?

This trial is currently completed. The enrollment target is 100 participants. The study started on 2004-06. Estimated completion is 2011-12.

What interventions are being tested in trial NCT00205192?

The interventions under investigation include: Cardiac resynchronization pacing (PROCEDURE).

Who is sponsoring clinical trial NCT00205192?

This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01048281 · 100 participants

    Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma

  • NCT01161199 · 100 participants

    The Use of Leukapheresis to Support HIV Pathogenesis Studies

  • NCT01327690 · 100 participants · Early Phase 1

    Mental Health in Veterans and Families After Group Therapies

  • NCT01730781 · 100 participants

    Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00205192, the US trial registry maintained by the National Library of Medicine. NCT00205192 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.